72 related articles for article (PubMed ID: 8804416)
1. Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity.
Chen Y; Plouffe C; Ménard R; Storer AC
FEBS Lett; 1996 Sep; 393(1):24-6. PubMed ID: 8804416
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cathepsin B by its propeptide: use of overlapping peptides to identify a critical segment.
Chagas JR; Ferrer-Di Martino M; Gauthier F; Lalmanach G
FEBS Lett; 1996 Sep; 392(3):233-6. PubMed ID: 8774851
[TBL] [Abstract][Full Text] [Related]
3. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide.
Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC
Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604
[TBL] [Abstract][Full Text] [Related]
4. Potent slow-binding inhibition of cathepsin B by its propeptide.
Fox T; de Miguel E; Mort JS; Storer AC
Biochemistry; 1992 Dec; 31(50):12571-6. PubMed ID: 1472493
[TBL] [Abstract][Full Text] [Related]
5. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.
Chan VJ; Selzer PM; McKerrow JH; Sakanari JA
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):113-7. PubMed ID: 10229665
[TBL] [Abstract][Full Text] [Related]
6. Identification of essential residues of CTLA-2alpha for inhibitory potency.
Deshapriya RM; Yuhashi S; Usui M; Kageyama T; Yamamoto Y
J Biochem; 2010 Mar; 147(3):393-404. PubMed ID: 19910310
[TBL] [Abstract][Full Text] [Related]
7. Residue-specific annotation of disorder-to-order transition and cathepsin inhibition of a propeptide-like crammer from D. melanogaster.
Tseng TS; Cheng CS; Hsu ST; Shih MF; He PL; Lyu PC
PLoS One; 2013; 8(1):e54187. PubMed ID: 23349821
[TBL] [Abstract][Full Text] [Related]
8. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
[TBL] [Abstract][Full Text] [Related]
9. [Brain cathepsin as dipeptidylcarboxypeptidase transforming provasopressor, pro-opioid and model peptides].
Azarian AV; Galoian AA
Vopr Med Khim; 1987; 33(5):78-81. PubMed ID: 3318115
[TBL] [Abstract][Full Text] [Related]
10. A model to explain the pH-dependent specificity of cathepsin B-catalysed hydrolyses.
Khouri HE; Plouffe C; Hasnain S; Hirama T; Storer AC; Ménard R
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):751-7. PubMed ID: 2039451
[TBL] [Abstract][Full Text] [Related]
11. An NMR-based identification of peptide fragments mimicking the interactions of the cathepsin B propeptide.
Yu Y; Vranken W; Goudreau N; de Miguel E; Magny MC; Mort JS; Dupras R; Storer AC; Ni F
FEBS Lett; 1998 Jun; 429(1):9-16. PubMed ID: 9657374
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core.
Mása M; Maresová L; Vondrásek J; Horn M; Jezek J; Mares M
Biochemistry; 2006 Dec; 45(51):15474-82. PubMed ID: 17176069
[TBL] [Abstract][Full Text] [Related]
13. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
Hall A; Dalbøge H; Grubb A; Abrahamson M
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
[TBL] [Abstract][Full Text] [Related]
14. Myostatin inhibitory region of fish (Paralichthys olivaceus) myostatin-1 propeptide.
Lee SB; Kim JH; Jin DH; Jin HJ; Kim YS
Comp Biochem Physiol B Biochem Mol Biol; 2016; 194-195():65-70. PubMed ID: 26827850
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of cathepsin S by its propeptide--specificity and mechanism of action.
Maubach G; Schilling K; Rommerskirch W; Wenz I; Schultz JE; Weber E; Wiederanders B
Eur J Biochem; 1997 Dec; 250(3):745-50. PubMed ID: 9461297
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition and stabilization of aspergilloglutamic peptidase by the propeptide. Identification of critical sequences and residues in the propeptide.
Kubota K; Nishii W; Kojima M; Takahashi K
J Biol Chem; 2005 Jan; 280(2):999-1006. PubMed ID: 15516690
[TBL] [Abstract][Full Text] [Related]
17. Demonstration by electrospray mass spectrometry that the peptidyldipeptidase activity of cathepsin B is capable of rat cathepsin B C-terminal processing.
Rowan AD; Feng R; Konishi Y; Mort JS
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):923-7. PubMed ID: 8379946
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic amino acids define the carboxylation recognition site in the precursor of the gamma-carboxyglutamic-acid-containing conotoxin epsilon-TxIX from the marine cone snail Conus textile.
Bush KA; Stenflo J; Roth DA; Czerwiec E; Harrist A; Begley GS; Furie BC; Furie B
Biochemistry; 1999 Nov; 38(44):14660-6. PubMed ID: 10545191
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
[TBL] [Abstract][Full Text] [Related]
20. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
